Published on July 23, 2026
What we love
Worth knowing
Our verdict
Buy RIZZ if you're metabolically curious — pre-diabetic, a biohacker, or an athlete who wants glucose trends without stabbing your arm daily. It's not for insulin-dependent T1D who need dosing-grade accuracy, or anyone who just wants a step counter. For everyone else chasing a full metabolic picture in one ring, it's the most interesting wearable on the market.
Ready to order? Visit Product →
Every glucose tracker until now came with a catch: a needle, a patch, or a sensor stuck to your arm for two weeks at a time. Ambrosia Systems spent nearly a decade in that world — and then built the way out. RIZZ is a smart ring that reads your glucose without breaking your skin, then stitches it together with sleep, stress, and recovery. If you've ever wanted the metabolic data without the commitment of a sensor, this is the pitch.
Ambrosia Systems started in San Francisco in 2016 with a stubborn idea: glucose monitoring shouldn't be locked behind clinics and finger-pricks. Back then, continuous glucose monitoring was expensive, invasive, and mostly aimed at people already deep in diabetes management.
Their first move was clever. In 2017 they shipped BluCon — a small device that turned the Abbott FreeStyle Libre into a real-time CGM for Type 1 and Type 2 patients. Suddenly a "scan-when-you-remember" sensor became a live data stream. That's the kind of engineering that comes from actually listening to patients.
The philosophy has stayed consistent for nearly ten years: make metabolic data continuous, affordable, and human. Not a demo. Not a lab curiosity. Real hardware in real hands. That track record matters, because the wearable space is crowded with companies promising the moon and shipping firmware updates. Ambrosia keeps shipping products people can hold.
Here's the thing that makes RIZZ genuinely different. Every mainstream CGM — Dexcom, Libre, all of them — puts a filament under your skin. RIZZ doesn't. It's the world's first non-invasive CGM in ring form. No pricks. No patches. No two-week sensor replacements. You put the ring on and it reads.
That alone would be a headline. But Ambrosia went further by refusing to make it a single-metric device. RIZZ pulls glucose trends together with sleep stages, stress index, heart rate, HRV, activity, blood oxygen, and skin temperature. One ring, one metabolic picture.
Why does that combination matter? Because glucose never happens in isolation. A bad night's sleep spikes your morning readings. A stressful meeting nudges your numbers before you've eaten anything. Most trackers show you these signals in separate silos — a sleep app here, a glucose patch there — and leave you to connect the dots. RIZZ connects them for you.
The company also engineered the glucose sensing to sip battery rather than drain it, which is the practical difference between a ring you wear constantly and one that lives on a charger. Ambrosia has been doing real-time CGM since 2017 — this isn't their first attempt at the hard part. That history shows in how the whole system is tuned to run continuously without you babysitting it.
Ambrosia's lineup tells the story of where they've been and where they're going. On the clinical, proven end sits BluCon — the device that converts FreeStyle Libre into a real-time CGM, paired with the LinkBluCon app for live readings, alerts, and trend data. That's for people who already use a Libre sensor and want it working harder.
Then there's RIZZ, the flagship for 2025 and beyond. This is the non-invasive smart ring that moves glucose tracking out of the medical-device category and into everyday wellness. It's built for people who want the insight without the sensor lifestyle.
Around those two products sits a broader platform: wellness tracking, fitness monitoring, and continuous glucose monitoring all feeding one AI system. So whether you come in as a patient managing Type 2, an athlete chasing performance, or someone just curious about their metabolism, there's a door in. The range covers clinical-grade at one end and everyday wearable at the other.
Picture a normal Tuesday. You wake up and RIZZ has already scored your sleep — but not in a vacuum. It shows how your glucose behaved overnight and ties that to your recovery score. You slept badly? You'll see it reflected in both your HRV and your morning glucose baseline.
You eat breakfast. The food insights feature reads how that meal moved your glucose, so you learn — over days, not guesses — that oatmeal spikes you but eggs don't. That's the loop that changes behaviour. No other ring on the market pairs a meal response with your actual glucose curve.
Through the day, the continuous stress index and HRV monitoring track how your body is coping. Big deadline? You'll watch stress climb and glucose drift with it. Then you train, and the multi-sensor activity tracking logs calories against your real metabolic data, not a generic formula.
Compare that to a standard fitness ring, which counts steps and estimates sleep, or a standard CGM, which shows glucose and nothing else. RIZZ is trying to be the one device that explains why your numbers move — and for the metabolically curious, that "why" is the whole point.
Let's be straight, because you're going to wonder. Non-invasive glucose sensing is newer than the needle-based kind. RIZZ is brilliant for tracking trends, patterns, and how your body responds to food, sleep, and stress. It is not positioned as a replacement for insulin-dosing decisions.
So who does that suit? If you're pre-diabetic, managing non-insulin Type 2, or simply optimising your metabolism, trend-grade data is exactly what you need — and you get it without a single skin puncture. If you're an insulin-dependent Type 1 who needs dosing-grade precision, Ambrosia's clinical BluCon path (with a Libre sensor) is the more appropriate tool. Knowing which product matches your needs is the difference between delight and disappointment here.
RIZZ is made for the metabolically curious. If you're pre-diabetic and want to head things off, this shows you which foods and habits move your numbers. If you're an athlete or fitness lover, it ties fuel to performance. If you're a busy professional chasing work-life balance, the stress and sleep integration is quietly powerful.
It's also ideal for anyone who's tried CGM patches and hated the sensor cycle. Finally, no adhesive on your arm.
Who should skip it? Insulin-dependent Type 1 patients who need dosing accuracy — go the BluCon clinical route instead. And anyone who just wants a cheap step counter. This is a metabolic instrument, not a pedometer.
Ambrosia sits in premium territory, and that's honest positioning. This isn't a $40 fitness band. You're paying for the world's first non-invasive glucose ring plus a multi-sensor AI platform in one wearable — a combination nobody else offers.
For context, Ambrosia already proved it can undercut on price: in 2021 they launched real-time CGM in India and other markets for under $1000 a year, dramatically below the usual cost of continuous monitoring. That instinct for value carries through.
Is the premium worth it? If you'd otherwise buy a smart ring and a separate CGM and a sleep tracker, RIZZ collapses all three into one device — and adds glucose without the sensor cost of patches every two weeks. For the metabolically serious, that math works. For casual users, it's more than you need.
Ambrosia Systems has done something the big CGM names spent years circling and never delivered: glucose tracking with no needle at all, wrapped in a ring you'll forget you're wearing. Back it with nearly a decade of real shipping history — BluCon in 2017, Apple Watch integration in 2019, affordable CGM in 2021 — and RIZZ reads as the natural next step, not a gamble.
Buy it if you're pre-diabetic, an athlete, or a biohacker who wants the full metabolic picture without the sensor lifestyle. Skip it if you need insulin-dosing accuracy or just want steps. For everyone in between, RIZZ is the most interesting wearable you can buy right now.